Investor Presentation on the Earnings conference call scheduled today, May 08, 2026.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Niva Bupa reported strong FY2026 results with GWP growing 27.4% YoY to ₹9,432.9 crore and PAT jumping 80.4% to ₹366.1 crore (IFRS basis). The combined insurance service ratio (CISR) improved to 101.4% from 103.0% in FY2025, showing operational efficiency gains. Retail health market share increased to 10.1% from 9.4%. Q4 FY2026 saw PAT of ₹157.8 crore, up 89.3% YoY. The expense ratio improved significantly to 36.5% from 39.2%, while claims ratio increased to 64.9% from 63.8%. The company serves 25.2 million active lives, up from 20.8 million. NPS improved to 60 from 55. IRDAI's mandate for Ind AS reporting starting April 2026 is noted as a positive transparency step.
Strong earnings beat with robust premium growth and significant PAT improvement signals healthy business momentum. Improved CISR and expense ratio indicate better operational efficiency. The market share gain in retail health segment is positive for competitive positioning.